{ "docId": "019de517-ef27-7380-abf1-7804147a21c1", "docSlug": "35bb8af5e32b82874d7685e3939f2cc9", "documentTitle": "Bausch+Lomb | Results Presentation Deck | 39 slides", "authorId": "bausch-lomb", "authorName": "Bausch + Lomb", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-02-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "pageCount": 39, "prevPage": 34, "nextPage": 36, "slideType": "revenue_buildup", "function": "decompose_segments", "density": "overcrowded", "nDataPoints": 72, "notes": null, "elementsJson": null, "metadataConfidence": 0.9, "imagePath": null, "slideHref": "/slides/019de517-ef27-7380-abf1-7804147a21c1/35", "deckHref": "/decks/019de517-ef27-7380-abf1-7804147a21c1", "deckJsonHref": "/decks/019de517-ef27-7380-abf1-7804147a21c1.json", "deckAnchorHref": "/decks/019de517-ef27-7380-abf1-7804147a21c1#slide-35", "components": [ { "bbox": { "h": 0.024, "w": 0.109, "x": 0.04, "y": 0.943 }, "kind": "image", "text": "BAUSCH+LOMB", "attrs": {}, "subkind": "logo", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "8526b969-9412-48ea-ace2-4536597293fc", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.017, "w": 0.018, "x": 0.94, "y": 0.948 }, "kind": "other", "text": "34", "attrs": {}, "subkind": null, "toolName": null, "toolSlug": null, "confidence": null, "componentId": "f125d69b-6e68-4c26-ae79-4d63593af6bb", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.116, "w": 0.745, "x": 0.158, "y": 0.859 }, "kind": "source-note", "text": "1. This is a non-GAAP measure or non-GAAP ratio. See Slide 1 and this Appendix for further information on non-GAAP measures and ratios. 2. Effective in the first quarter of 2023, certain products historically included in the reported results of the Pharmaceuticals segment are now included in the reported results of the Vision Care segment and certain products included in the reported results of the Vision Care segment are now included in the reported results of the Pharmaceuticals segment. Management believes these movements are necessary in order to better align these products with the groupings of similar products. The net impact of these product movements was not material to the periods presented. Prior period presentations of segment revenues have been conformed to the current segment reporting structure. 3. The impact for changes in foreign currency exchange rates is determined as the difference in the current period reported revenues at their current period currency exchange rates and the current period reported revenues revalued using the monthly average currency exchange rates during the comparable prior period. 4. As of the first quarter of 2023, certain products were recategorized across the consumables, implantables and equipment product categories. This change was made as management believes this better aligns these products in their respective categories. Prior period presentations of product categories have been conformed to current product category structure to allow investors to evaluate results between periods on a consistent basis. 5. Contact Lens Revenue Impact of distribution facility disruptions is approximately $37M.", "attrs": {}, "subkind": null, "toolName": null, "toolSlug": null, "confidence": null, "componentId": "aac05b70-81aa-44eb-ab0c-9aa59b8d9b7d", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.409, "w": 0.698, "x": 0.255, "y": 0.149 }, "kind": "table", "text": "Calculation of Constant Currency Revenue for the Twelve Months Ended December 31, 2023 December 31, 2022 Change in Reported Revenue Change in Constant Currency Revenue¹ Revenue as Reported Changes in Exchange Rates³ Constant Currency Revenue (Non- GAAP)¹ Revenue as Reported Amount Pct. Amount Pct. Contact Lens 891 24 915 869 22 3% 46 5% Consumer² 1,652 37 1,689 1,500 152 10% 189 13% Surgical Consumables 394 394 359 35 10% 35 10% Surgical Implantables 184 2 186 188 (4) -2% (2) -1% Surgical Equipment 189 (1) 188 171 18 11% 17 10% Contact Lens (excluding impact of distribution facility 928 24 952 869 59 7% 83 10% disruptions¹,5)", "attrs": {}, "subkind": "data", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "17d4ff75-edc7-46d4-895e-c257056d9c30", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.202, "w": 0.698, "x": 0.255, "y": 0.629 }, "kind": "table", "text": "Calculation of Constant Currency Revenue for the Twelve Months Ended December 31, 2022 December 31, 2021 Change in Reported Revenue Change in Constant Currency Revenue¹ Revenue as Reported Changes in Exchange Rates³ Constant Currency Revenue (Non- GAAP)¹ Revenue as Reported Amount Pct. Amount Pct. Bausch + Lomb 3,768 184 3,952 3,765 3 0% 187 5%", "attrs": {}, "subkind": "data", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "9ec3dce3-3e58-4503-aefe-2163d55e3211", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.06, "w": 0.803, "x": 0.049, "y": 0.036 }, "kind": "title", "text": "Reconciliation of Reported Revenue to Constant Currency Revenue¹ and Constant Currency Revenue Growth¹ ($M)", "attrs": {}, "subkind": "headline", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "0154b387-ae42-4ecb-8412-a92986154bde", "frameworkName": null, "frameworkSlug": null } ], "metrics": [], "tools": [ { "name": "Table data", "slug": "table-data", "agent": null, "layer": "slide", "matchId": "4fddda3c-56a7-4ab2-817d-c178d9cfe298", "evidence": "table/data: Calculation of Constant Currency Revenue for the Twelve Months Ended December 31, 2023 December 31, 2022 Change in Reported Revenue Change in Constant Currency Revenue¹ Revenue as Reported Changes in Exchange", "confidence": 0.9 } ], "frameworks": [], "arcBeats": [ { "to": 39, "from": 22, "beatId": "8c7af079-c074-453d-8134-b8959b29a800", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Satisfaction", "beatSlug": "monroes-sequence-satisfaction", "evidence": "The appendix and Q&A section provide satisfaction and answers to questions", "position": 4, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "loops": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }